The genus Virgaria was first proposed in 1817 1 and classified in the family Xylariaceae. 2 Virgaria nigra, a type species of Virgaria, is a commonly encountered hyphomycetes and has been illustrated in numerous publications. [3] [4] [5] However, little work has been done on the chemical constituents of Virgaria species, and only one compound, vinigrol, has previously been isolated from V. nigra. 6 As part of our interest in the presence of novel metabolites in Virgaria sp., we investigated the chemical constituents of a culture broth of a newly discovered Virgaria sp. FKI-4860 that resulted in the isolation of a new compound, virgaricin (1). This compound was found to be an analog of pramanicins and TMC-260. [7] [8] [9] In this study, we describe the isolation, structure elucidation and antimicrobial activity of 1.
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Fungal strain FKI-4860 was isolated from a soil sample collected in the Bonin Islands, Tokyo, Japan. It is characterized by olive gray colonies, and solitary, mainly reniform and light brown sympodial conidia. The rDNA internal transcribed spacer (ITS) sequence of strain FKI-4860 was elucidated and deposited at the DNA Data Bank of Japan, with the accession number AB670709. With respect to sequence distances elucidated by the MegAlign programs from the Lasergene 9 package (DNAStar Inc., Madison, WI, USA), FKI-4860 had 90% similarity with the ITS sequences of V. nigra CBS 525.69 (AB670712). From the results of morphological characteristics and sequence analysis, strain FKI-4860 was identified as a novel species of Virgaria. 10 Strain FKI-4860 was grown and maintained on a LcA slant consisting of 0.1% glycerol, 0.08% KH 2 PO 4 , 0.02% K 2 HPO 4 , 0.02% MgSO 4 Á7H 2 O, 0.02% KCl, 0.2% NaNO 3 , 0.02% yeast extract and 1.5% agar (adjusted to pH 6.0 before sterilization). A loop of spores of Virgaria sp. FKI-4860 was inoculated into 10 ml of seed medium, which consisted of 2.0% glucose, 0.2% yeast extract, 0.5% Polypepton (Wako Pure Chemical Industries, Osaka, Japan), 0.05% MgSO 4 Á7H 2 O, 0.1% KH 2 PO 4 and 0.1% agar (adjusted to pH 6.0 before sterilization), in a test tube. The inoculated tube was incubated on a rotary shaker (300 r.p.m.) at 27 1C for 3 days.
For the production of 1, a 1-ml portion of the seed culture was transferred to each of four 500-ml Erlenmeyer flasks containing 100 ml of the production medium, consisting of 3.0% sucrose, 3.0% soluble starch, 1.0% malt extract, 0.3% Ebios (Mitsubishi Tanabe Pharma Co., Osaka, Japan), 0.5% KH 2 PO 4 and 0.05% MgSO 4 Á7H 2 O (adjusted to pH 6.0 before sterilization). Fermentation was carried out statically at 22 1C for 17 days.
The whole culture broth (400 ml) was subsequently added to an equal amount of ethanol and then filtered. The filtrate was concentrated, under reduced pressure, to remove the ethanol and then extracted with ethyl acetate. The organic layer was concentrated to dryness in vacuo to afford a crude extract (306 mg). The ethyl acetate extract was chromatographed on a silica gel column (1.7fÂ15 cm, Silica gel 60, Merck, Darmstadt, Germany), using a chloroform/ methanol gradient solvent system of increasing the polarity, to yield four fractions. The concentrated fraction (21.5 mg) eluted with chloroform/methanol (8/2) was subjected to reversed-phase HPLC (XBridge Prep C18, Waters, Milford, MA, USA) with 40% acetonitrile at 3 ml min À1 detected at UV 210 nm to give 1 (3.3 mg).
Compound Figure 1 . HMBC correlations between H 2 -14/C-16, H 2 -15/C-16 and C-17, and H 2 -16/C-17 and C-18 established the C-15 to C-17 connection. The large vicinal coupling constants (J 8,9 ¼15.1, J 10,11 ¼14.7, and J 12,13 ¼14.9 Hz) indicated that all olefinic bonds had the E configuration. The ROESY correlations observed between H-8/H-10, H-9/H-11, H-10/H-12 and H-11/H-13 also supported this deduction. Furthermore, HMBC correlations from H-8 and H-9 to the carbonyl carbon at C-7 (d 197.8) clarified the sidechain structure of (2E,4E,6E)-dodeca-2,4,6-trien-1-one moiety. The IR absorbance at 1670 cm À1 supported the presence of an a,b-unsaturated carbonyl group. The HMBC correlations of NH-1/ C-4 and C-5, OH-3/C-2, C-3 and C-4, H-4/C-3 and OH-4/C-3 suggested a 4-amino-2,3,5-trihydroxypentanoyl moiety, and the correlation between NH-1/C-3 indicated it was cyclized to form a g-lactam ring, which was supported by the IR absorption at 1710 cm À1 . Finally, HMBC correlations from OH-3 and H-4 to C-7 indicated that the g-lactam moiety was attached directly to the carbonyl carbon at C-7. On the basis of these findings, the planar structure of 1 was elucidated as shown in Figure 2 .
The relative stereochemistry of 1 was elucidated by the ROESY experiment. The ROESY correlations between OH-3/H-4, OH-3/H-6a (d 3.31) and H-4/H-6a (d 3.31) showed that these protons were located on the same side of the molecule. The ROESY correlations between OH-4/H-8 and H-5/H-8 indicated that OH-4 and H-5 were located on the same face of the molecule. This was supported by the similarities of 13 C NMR data in CD 3 OD (Table 1) between 1 and pramanicins, 7, 8 indicating the same relative configurations at C-3, C-4 and C-5. In consequence, the relative stereochemistry of 1 in the g-lactam moiety was assigned to be the same as for pramanicins.
The bioactivity of 1 provides some interesting insight into structure/activity relationships. The antimicrobial activity of 1 was evaluated by a paper disc method (6 mm, Advantec Toyo Kaisha, Tokyo, Japan), as previously described. 11 The microorganisms used included Aspergillus niger KF 103 (ATCC 6275), Bacillus subtilis KB 211 (ATCC 6633), Candida albicans KF 1, Escherichia coli KB 213 (NIHJ), Micrococcus luteus KB 212 (ATCC 9341), Mucor racemosus KF 223 (IFO 4581), Saccharomyces cerevisiae KF 237 (ATCC 9763) and Xanthomonas campestris pv. oryzae KB 88. In essence, 1 expressed virtually no bioactivity, proving only weak activity against B. subtilis at 100 mg per disc. However, pramanicin exhibits potent antifungal activity against a variety of fungal pathogens, including C. albicans and Cryptococcus neoformans, as well as antibacterial activity against B. subtilis. 7, 12 Pramanicin has also been reported to cause endothelialdependent relaxation of rat aorta, although the activity of pramanicin A (in which the causative epoxide group was changed to a double bond) was weak. 13 While pramanicin's side-chains have two more carbons than 1, the side-chain carbon number of TMC-260, an IL-4 signal transduction inhibitor produced by Acremonium kiliense, 9 was the same as that of 1. Virgaricin produced by Virgaria sp. FKI-4860 T Ishii et al
